Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CYP2A6 Antikörper (C-Term)

CYP2A6 Reaktivität: Human WB, ELISA, IF, IHC (p) Wirt: Maus Monoclonal F16 P2 D8 unconjugated
Produktnummer ABIN533615
  • Target Alle CYP2A6 Antikörper anzeigen
    CYP2A6 (Cytochrome P450, Family 2, Subfamily A, Polypeptide 6 (CYP2A6))
    Bindungsspezifität
    • 15
    • 6
    • 4
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reaktivität
    • 43
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 37
    • 6
    Maus
    Klonalität
    • 38
    • 5
    Monoklonal
    Konjugat
    • 25
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser CYP2A6 Antikörper ist unkonjugiert
    Applikation
    • 38
    • 14
    • 13
    • 13
    • 7
    • 6
    • 4
    • 4
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Verwendungszweck
    Mouse monoclonal antibody raised against synthetic peptide of CYP2A6.
    Kreuzreaktivität
    Human
    Produktmerkmale
    Antibody Reactive Against Synthetic Peptide.
    Immunogen
    A synthetic peptide corresponding to C-terminus of human CYP2A6.
    Klon
    F16 P2 D8
    Isotyp
    IgG1
    Top Product
    Discover our top product CYP2A6 Primärantikörper
  • Applikationshinweise
    Western Blot (1-2 μg/mL)
    The optimal working dilution should be determined by the end user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    In PBS (0.08 % sodium azide)
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C.
    Aliquot to avoid repeated freezing and thawing.
  • Higashi, Nakajima, Katoh, Tokudome, Yokoi: "Inhibitory effects of neurotransmitters and steroids on human CYP2A6." in: Drug metabolism and disposition: the biological fate of chemicals, Vol. 35, Issue 4, pp. 508-14, (2007) (PubMed).

    Audrain-McGovern, Al Koudsi, Rodriguez, Wileyto, Shields, Tyndale: "The role of CYP2A6 in the emergence of nicotine dependence in adolescents." in: Pediatrics, Vol. 119, Issue 1, pp. e264-74, (2007) (PubMed).

    Swan, Benowitz, Lessov, Jacob, Tyndale, Wilhelmsen: "Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence." in: Pharmacogenetics and genomics, Vol. 15, Issue 2, pp. 115-25, (2005) (PubMed).

  • Target
    CYP2A6 (Cytochrome P450, Family 2, Subfamily A, Polypeptide 6 (CYP2A6))
    Andere Bezeichnung
    CYP2A6 (CYP2A6 Produkte)
    Synonyme
    CPA6 antikoerper, CYP2A antikoerper, CYP2A3 antikoerper, CYPIIA6 antikoerper, P450C2A antikoerper, P450PB antikoerper, cyp2a6 antikoerper, cytochrome P450 family 2 subfamily A member 6 antikoerper, cytochrome P450 2A6 antikoerper, cytochrome P450 family 2 subfamily A member 6 L homeolog antikoerper, CYP2A6 antikoerper, cyp2a6.L antikoerper
    Gen-ID
    1548
Sie sind hier:
Kundenservice